Regulatory lag is slowing real-time risk pricing in insurance

Regulatory Lag Stalls Real-Time Risk Pricing in Insurance, Experts Warn

New York, NY – August 28, 2025

As insurance companies harness artificial intelligence and big data to revolutionize risk assessment, a growing obstacle threatens to derail progress: regulatory lag. Industry leaders, including Rajiv Matta, Chief Innovation Officer at Pinnacle Insurance Solutions, are sounding the alarm that outdated regulatory frameworks are slowing the adoption of hyper-personalized, real-time risk pricing, leaving insurers unable to fully leverage cutting-edge technology. This gap between innovation and oversight is creating friction in an industry poised to transform how premiums are calculated, with implications for both insurers and consumers.

Trending: AI-Powered Insurance Hits Regulatory Roadblocks

The insurance sector is undergoing a seismic shift, driven by AI and predictive analytics that allow insurers to tailor premiums to individual behaviors and real-time data, such as driving habits or lifestyle changes. However, as Matta highlighted in a recent interview with Insurance Business America, regulators are struggling to keep pace. “We have the data and methodology to price risks dynamically, but regulators are still stuck in rate cycles requiring approvals that can take months,” he said. For instance, small changes like a customer purchasing a high-risk item—say, a backyard trampoline—could alter their risk profile, but regulatory delays prevent immediate pricing adjustments. This bottleneck stifles innovation and limits insurers’ ability to offer competitive, fair pricing.

The issue is particularly acute as 91% of insurers are investing in AI, with one in ten specialty insurers planning to scale AI use in 2025, according to Deloitte’s 2025 Global Insurance Outlook. Yet, 84% of actuaries express concerns about a lack of technical expertise to navigate regulatory hurdles, and only 43% of underwriters trust automated AI recommendations due to compliance uncertainties. These challenges underscore a broader tension: while technology enables real-time risk profiling, state-by-state regulations—often rooted in decades-old frameworks—require lengthy approval processes for rate changes, creating a mismatch that frustrates innovation.

A Call for Collaboration Amid Rising Stakes

Matta compared the situation to Delta Airlines’ controversial use of AI for dynamic seat pricing, a practice facing less scrutiny in the less-regulated airline industry. “Everybody’s risk is unique, so there’s resistance to dynamic pricing in insurance,” he noted, urging stronger collaboration between insurers and regulators to streamline approvals without compromising consumer protections. Controlled testing environments, like regulatory sandboxes, have helped some insurers pilot new AI-driven products, but widespread adoption remains elusive as regulators in many states only recently approved predictive models.

The consequences of this lag are significant. Insurers face higher costs to maintain compliance across diverse state regulations, with 75% of U.S. firms vulnerable to penalties for missteps, per a 2024 Hanover Search report. Meanwhile, consumers miss out on personalized premiums that could reward safer behaviors, such as telematics-based auto insurance that adjusts rates based on real-time driving data. “AI can transform insurers into real-time risk managers, but only if regulators adapt,” said Joel Pepera of Arity, a data science firm, emphasizing the potential for reduced bias in pricing for underserved groups.

The Path Forward: Balancing Speed and Safety

As the global insurance pricing optimization market is projected to grow from $1.89 billion in 2024 to $5.69 billion by 2033, driven by AI and analytics, the need for regulatory reform is urgent. Experts advocate for harmonized standards, like those proposed by the International Association of Insurance Supervisors, to reduce compliance burdens and enable faster deployment of innovative pricing models. Such reforms could mirror Europe’s Solvency II framework, which uses risk-based capital assessments to balance innovation with financial stability.

On X, the topic is gaining traction, with users posting about the need for “smarter regulations to match AI’s speed” and warning that “lagging rules hurt consumers more than insurers.” Insurers are also exploring alternative solutions, such as parametric insurance, which triggers payouts based on predefined data points, bypassing traditional rate cycles. Yet, without regulatory agility, the industry risks falling short of its potential to deliver fair, responsive coverage in an increasingly complex world. As Matta put it, “Scale innovation with proof, and build regulator relationships early.” The clock is ticking for policymakers to catch up.

An Open Invitation to Worldwide Clients

Satish Mehra and VSD Regulatory Affairs Consultant are now actively inviting manufacturers, importers, and regulatory professionals from across the world to partner for their medical device import needs. Whether you’re a startup launching innovative diagnostics or an established firm expanding into Asia, VSD offers the expertise to navigate CDSCO with confidence.

Interested parties can reach out directly to Satish Mehra at +91-8920964801 via WhatsApp or phone for a free initial consultation. Visit his LinkedIn profile or Facebook page for more details on services and success stories.

As the global medical device industry continues to integrate, consultants like Mehra are pivotal in fostering international collaboration. This invitation not only opens doors to India’s thriving market but also promises a compliant, efficient pathway to success. For those ready to import innovation, VSD Regulatory Affairs is your trusted ally.

Leave a Comment